CAS: 918504-65-1; N-(3-(5-(4-Chlorophenyl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl)-2,4-Difluorophenyl)Propane-1-Sulfonamide

该化合物是一种小分子药物,主要用于治疗某些种类的黑素瘤,特别是BRAF V600E突变的黑素瘤,它是BRAF蛋白质的选择性抑制剂,它是MAPK信号路径的一部分,它控制细胞生长和分裂.通过抑制这种突变蛋白,Vemurafenib有助于减缓或阻止癌症细胞的扩散.该化合物的特征是其相对较低的分子重量和具体的结构特征,使其与BRAF 脂酶域有约束力.Vemurafenib是口服的,并且与各种副作用有关,包括皮肤皮疹,联合疼痛和疲劳等.它的开发标志着定向癌症疗法取得显著进展,表明个性化医学在肿瘤学中的重要性.该药物经常与其他治疗一起使用,以提高功效和管理抗药性.许多有针对性的疗法,在治疗期间,对不利影响和治疗反应进行监测至关重要.

结构式图片

欧盟法规

C&L通报

上下游产品

propane-1-sulfonic acid {3-[5-(4-chlorophenyl) 1-(2,6-dichloro-benzoyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide 5-bromo-2-pyridylamine 4-Chlorophenylboronic acid 2,6-difluoro-3-(propane-1-sulfonylamino)benzoic acid1-(5-(4-chlorophenyl)-3-(2,6-difluoro-3-(propylsulfonamido)benzoyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)ethyl dihydrogen phosphate (S)-2-amino-N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)-3-methyl-N-(propylsulfonyl)butanamide hydr°Chloride

合成工艺路线路线简述

  • 1262985-23-8 = 918504-65-1
    反应条件:1.1 Reagents: Ammonia Solvents: Methanol,Dimethylformamide; 18 H,25 °C -> 55 °C1.2 Solvents: Methanol; 30 Min,45 - 55 °C; 55 °C -> 25 °C; Overnight,4 °C
    标题:Solid State Forms Of Vemurafenib Hydrochloride And Preparation
    参考文献:World Intellectual Property Organization]

    918516-27-5 + 1186194-32-0 = 918504-65-1
    反应条件:1.1 Reagents: Aluminum Chloride Solvents: 1,2-Dichloroethane; 10 Min,0 °C; 30 Min,Cooled1.2 Solvents: 1,2-Dichloroethane; 40 Min,Cooled; Overnight,0 - 20 °C
    标题:Preparation Of Crystalline Forms Of Vemurafenib
    参考文献:World Intellectual Property Organization]

    1679-18-1 + 918504-27-5 = 918504-65-1
    反应条件:1.1 Reagents: Potassium Carbonate Catalysts: Dichlorobis(Triphenylphosphine)Palladium Solvents: Dimethylformamide; 20 - 25 °C; 10 - 20 Min,25 - 30 °C; 30 °C -> 105 °C; 6 H,95 - 105 °C
    标题:Substantially Pure Vemurafenib
    参考文献:India]

    1679-18-1 + 918504-27-5 = 918504-65-1
    反应条件:1.1 Reagents: Potassium Carbonate Catalysts: Tetrakis(Triphenylphosphine)Palladium Solvents: Dimethylformamide; 10 - 20 Min,25 - 30 °C; 6 H,30 °C -> 105 °C
    标题:Substantially Pure Vemurafenib And Its Salts
    参考文献:World Intellectual Property Organization]

    1782069-68-4 + 10147-36-1 = 918504-65-1
    反应条件:1.1 Reagents: Pyridine Solvents: Tetrahydrofuran; 10 - 15 Min,25 - 35 °C; 8 H,25 - 35 °C
    标题:A Novel Process For Preparing Vemurafenib
    参考文献:India]

    1227958-55-5 = 918504-65-1
    反应条件:1.1 Reagents: 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone Solvents: 1,4-Dioxane,Water; 3 H,Rt1.2 Reagents: Sodium Bicarbonate Solvents: Water; 20 - 30 Min,Rt; 10 Min,Rt
    标题:Novel Processes For The Preparation Of Vemurafenib
    参考文献:World Intellectual Property Organization]

    = 918504-65-1 [标题:Reaction Conditions
    标题:Preparation Of Conjugate Compounds For The Degradation Of Raf
    参考文献:World Intellectual Property Organization]

    1262985-23-8 = 918504-65-1
    反应条件:1.1 Reagents: Ammonia Solvents: Methanol; 20 - 25 °C; 25 °C -> 55 °C; 10 - 20 H,50 - 55 °C
    标题:Process For Preparation Of N-[3-[[5-(4-Chlorophenyl)-1H-Pyrrolo[2,3-B]Pyridin-3-Yl]Carbonyl]-2,4-Difluorophenyl]-1-Propanesulfonamide
    参考文献:United States]

    1227958-55-5 = 918504-65-1
    反应条件:1.1 Reagents: 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone Solvents: 1,4-Dioxane,Water; Rt; 10 Min,100 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water
    标题:Rapid,Microwave-Assisted Organic Synthesis Of Selective V600Ebraf Inhibitors For Preclinical Cancer Research
    作者:Buck,Jason R.; Saleh,Sam; Imam Uddin,Md.; Manning,H. Charles
    参考文献:Tetrahedron Letters 日期:2012 卷标:53(32) 页码:4161-4165]

    4637-24-5 + 2396525-97-4 + 4251-65-4 = 918504-65-1
    反应条件:1.1 Reagents: 1,8-Diazabicyclo[5.4.0]Undec-7-Ene Solvents: 1,2-Dichloroethane; 5 H,71 - 73 °C; 73 °C -> 30 °C1.2 5 H,90 - 95 °C; 95 °C -> 30 °C1.3 Reagents: Ammonia Solvents: Methanol; 4 H,50 - 55 °C
    标题:Simple Preparing Method Of Vemurafenib Or Analogue Thereof
    参考文献:China]

    918516-27-5 + 1186194-32-0 = 918504-65-1
    反应条件:1.1 Reagents: Aluminum Chloride Solvents: Dichloromethane; 30 Min,0 - 5 °C1.2 2 H
    标题:A Process For Preparation Of Amorphous Vemurafenib
    参考文献:India]

    1262985-23-8 = 918504-65-1
    反应条件:1.1 Reagents: Ammonia Solvents: Methanol,Tetrahydrofuran; 24 H,28 - 35 °C
    标题:Process For Preparation Of Diprotected Pyrrolo[2,3-B]Pyridine Intermediates Useful In Industrial Scale Production Of Biologically Active Compounds
    参考文献:United States]

    918516-27-5 + 1103234-56-5 = 918504-65-1
    反应条件:1.1 Reagents: Oxalyl Chloride Catalysts: Dimethylformamide Solvents: Dichloromethane; 30 Min,Rt; 2 H,Rt1.2 Reagents: Aluminum Chloride Solvents: Dichloromethane; 3 H,Rt
    标题:Method For Preparation Of N-{3-[5-(4-Chlorophenyl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluorophenyl} Propane-1-Sulfonamide
    参考文献:World Intellectual Property Organization]

    918516-27-5 + 1103234-56-5 = 918504-65-1
    反应条件:1.1 Reagents: Oxalyl Chloride Catalysts: Dimethylformamide Solvents: Dichloromethane; 1 H,20 - 25 °C; 3 H,20 - 25 °C1.2 Reagents: Aluminum Chloride Solvents: Dichloromethane; 30 Min,0 - 5 °C; 5 °C -> 20 °C1.3 Reagents: Pyridine Solvents: Dichloromethane; 3 H,20 - 25 °C1.4 Reagents: Water; 0 °C
    标题:An Improved Process For The Preparation Of Vemurafenib
    参考文献:India]

    918516-27-5 + 1103234-56-5 = 918504-65-1
    反应条件:1.1 Catalysts: Aluminum Chloride Solvents: Dichloromethane; 0 - 5 °C1.2 Reagents: Oxalyl Chloride Solvents: Dichloromethane; Rt; 2 H,Rt1.3 5 H,Rt1.4 Reagents: Water; 1 H,Rt
    标题:New Processes For The Preparation Of Vemurafenib
    参考文献:World Intellectual Property Organization]

    = 918504-65-1
    反应条件:1.1 Reagents: Ammonia Solvents: Methanol,Dimethylacetamide; 25 - 30 °C; 30 °C -> 55 °C; 4 H,55 °C; 55 °C -> 30 °C1.2 Solvents: Methanol; 25 - 30 °C; 3 H,25 - 30 °C
    标题:Improved Process For The Preparation Of Propane-1-Sulfonic Acid {3-[5-(4-Chlorophenyl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluoro-Phenyl}-Amide
    参考文献:India]

    = 918504-65-1
    反应条件:1.1 Reagents: Ammonia Solvents: Methanol,Dimethylacetamide; 30 °C -> 55 °C; 24 H,50 - 55 °C
    标题:A Process For The Preparation Of Vemurafenib
    参考文献:India]

    918516-27-5 + 1186194-32-0 = 918504-65-1
    反应条件:1.1 Reagents: Aluminum Chloride Solvents: Dichloromethane; 0 °C; 10 Min,3 °C1.2 Solvents: Dichloromethane; 25 Min,0 °C -> 5 °C; 0 °C -> 25 °C; 3 H,25 °C
    标题:Process For The Preparation Of Vemurafenib And Its Intermediates
    参考文献:India]

    = 918504-65-1 [标题:Reaction Conditions
    标题:Simultaneously Improving The Physicochemical And Pharmacokinetic Properties Of Vemurafenib Through Cocrystallization Strategy
    作者:Huang,Guan-Lan; Yang,Ling; Ren,Bo-Ying; Lv,Xin-Yue; Song,Ling-Yi; Et Al
    参考文献:Journal Of Drug Delivery Science And Technology 日期:2022 卷标:70
📜(4-氯苯基)乙醛置于氨,1,8-二氮杂双环[5.4.0]十一碳-7-烯,Zinc(II) Chloride体系中,用 甲醇,环己烷,1,2-二氯乙烷 作为反应溶剂,化学反应 18.0H,反应生成 维罗非尼
参考文献:一种维罗非尼及其类似物的简便制备方法
标题:一种维罗非尼及其类似物的简便制备方法
摘要:本发明提供一种维罗非尼及其类似物的简便制备方法,利用对位取代苯乙醛ⅱ和n‑[2,4‑二取代基‑3‑(氰基正丙酰基)苯基]正丙磺酰胺ⅲ在碱催化下共沸除水,发生缩合反应,所得缩合产物和甲叉化试剂v(N,N‑二甲基甲酰胺缩二醇或原甲酸三酯)缩合,再与氨环化得到维罗非尼或其类似物.利用本发明的方法制备维罗非尼成本低,工艺条件温和,操作要求低,反应时间短,生产效率高,并且工艺流程操作简便,废水产生量少,绿色环保,收率和纯度高,有利于维罗非尼的绿色工业化生产.同时本发明的方法可制备维罗非尼类似物,对于开展类似化合物的药效研究具有重要意义.

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Silva KAS, Magalhães IMQS, Benincasa DER, Cecconello DK, Michalowski MB. Targeted Therapy With Vemurafenib in Brazilian Children With Refractory Langerhans Cell Histiocytosis: Two Case Reports and Review of Literature. Cancer Rep (Hoboken). 2024 Aug;7(8):e2142. doi: 10.1002/cnr2.2142.
2: Dugan MM, Perez MC, Karapetyan L, Zager JS. Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation- Positive Melanoma: Patient Selection and Perspectives. Cancer Manag Res. 2024 Jul 29;16:933-939. doi: 10.2147/CMAR.S325514.
3: Yu N, Raslan OA, Lee HS, Theeler BJ, Raafat TA, Fragoso R, Shahlaie K, Aboud O. Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review. CNS Oncol. 2024 Jan 1;13(1):CNS106. doi: 10.2217/cns-2023-0018. Epub 2024 Feb 13.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知